carbachol has been researched along with Pulmonary Eosinophilia in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Pulmonary Eosinophilia: A condition characterized by infiltration of the lung with EOSINOPHILS due to inflammation or other disease processes. Major eosinophilic lung diseases are the eosinophilic pneumonias caused by infections, allergens, or toxic agents.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buijs, J | 2 |
| Egbers, MW | 2 |
| Lokhorst, WH | 1 |
| Savelkoul, HF | 1 |
| Nijkamp, FP | 2 |
2 other studies available for carbachol and Pulmonary Eosinophilia
| Article | Year |
|---|---|
Toxocara-induced eosinophilic inflammation. Airway function and effect of anti-IL-5.
Topics: Animals; Antibodies, Monoclonal; Bronchoalveolar Lavage Fluid; Carbachol; Eosinophilia; Eosinophils; | 1995 |
Toxocara canis-induced airway eosinophilia and tracheal hyporeactivity in guinea pigs and mice.
Topics: Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Carbachol; Dinoprostone; Dose-Resp | 1995 |